The British pharma giant will hand off its experimental itch treatment to Italian company Alfasigma as it focuses on broader ...

BioVie is eyeing a $19.7 million IPO for a spinout focused on bringing a new formulation of an approved kidney failure drug to market as a potential treatment for liver disease. | BioVie is eyeing a ...

Cirrhosis is a severe form of liver scarring that may increase your risk of complications and dying. There’s no cure for cirrhosis, but a doctor may recommend a liver transplant surgery if you have ...

Resmetirom improved HRQOL versus placebo in early MASH, particularly abdominal symptoms, disease-related worry, and health distress, with onset by week 24 and durability through week 52. Baseline ...

In most cases, cirrhosis cannot be reversed. It’s a severe form of liver damage characterised by permanent scarring. Recent studies have found that some damage from cirrhosis may be reversible. But ...

Researchers at Lund University, with international collaborators, have identified altered liver gene expression linked specifically to fibrosis in metabolic dysfunction-associated steatotic liver ...

Please provide your email address to receive an email when new articles are posted on . Staying up-to-date on screening at least 50% of the time in the 4 years before a diagnosis of HCC correlated ...

Fatty liver disease is when too much fat builds up in the liver. The liver is the body’s filter. It helps clean your blood, ...

Fatty liver disease can often be reversed without medication, especially in its early stages. The key drivers are insulin ...

What Is Metabolic Dysfunction-Associated Steatohepatitis? Metabolic dysfunction-associated steatohepatitis, or MASH, is a form of liver disease. MASH occurs when fat accumulates in liver cells. Plenty ...